Des troubles digestifs peuvent-ils résulter d'un déséquilibre de GIP ?
Oui, un déséquilibre peut entraîner des troubles digestifs comme des ballonnements.
Troubles digestifsBallonnements
#4
Le GIP influence-t-il le risque d'obésité ?
Oui, des niveaux anormaux de GIP peuvent contribuer au développement de l'obésité.
ObésitéGastric Inhibitory Polypeptide
#5
Le GIP est-il impliqué dans des troubles endocriniens ?
Oui, des anomalies du GIP peuvent être liées à des troubles endocriniens comme le syndrome métabolique.
Syndrome métaboliqueTroubles endocriniens
Facteurs de risque
5
#1
Quels facteurs augmentent le risque de déséquilibre du GIP ?
L'obésité, le diabète et un mode de vie sédentaire augmentent le risque.
ObésitéDiabète
#2
L'alimentation influence-t-elle le GIP ?
Oui, une alimentation riche en sucres et en graisses peut perturber le GIP.
AlimentationSucres
#3
Le manque d'exercice est-il un facteur de risque pour le GIP ?
Oui, un mode de vie inactif peut contribuer à des déséquilibres du GIP.
Inactivité physiqueGastric Inhibitory Polypeptide
#4
Le stress chronique affecte-t-il le GIP ?
Oui, le stress chronique peut perturber la sécrétion de GIP et la régulation de la glycémie.
Stress chroniqueGlycémie
#5
L'âge influence-t-il les niveaux de GIP ?
Oui, les niveaux de GIP peuvent varier avec l'âge, affectant la régulation métabolique.
ÂgeRégulation métabolique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Peptide gastrointestinal : Questions médicales les plus fréquentes",
"headline": "Peptide gastrointestinal : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Peptide gastrointestinal : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-06",
"dateModified": "2026-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Peptide gastrointestinal"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neuropeptides",
"url": "https://questionsmedicales.fr/mesh/D009479",
"about": {
"@type": "MedicalCondition",
"name": "Neuropeptides",
"code": {
"@type": "MedicalCode",
"code": "D009479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Peptide gastrointestinal",
"alternateName": "Gastric Inhibitory Polypeptide",
"code": {
"@type": "MedicalCode",
"code": "D005749",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shunsuke Yamane",
"url": "https://questionsmedicales.fr/author/Shunsuke%20Yamane",
"affiliation": {
"@type": "Organization",
"name": "Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan."
}
},
{
"@type": "Person",
"name": "Norio Harada",
"url": "https://questionsmedicales.fr/author/Norio%20Harada",
"affiliation": {
"@type": "Organization",
"name": "Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan."
}
},
{
"@type": "Person",
"name": "Li Li",
"url": "https://questionsmedicales.fr/author/Li%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology."
}
},
{
"@type": "Person",
"name": "Carolyn F Deacon",
"url": "https://questionsmedicales.fr/author/Carolyn%20F%20Deacon",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences and NovoNordisk Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Panum Institute, Copenhagen, Denmark."
}
},
{
"@type": "Person",
"name": "Jens J Holst",
"url": "https://questionsmedicales.fr/author/Jens%20J%20Holst",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences and NovoNordisk Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Panum Institute, Copenhagen, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity.",
"datePublished": "2024-07-10",
"url": "https://questionsmedicales.fr/article/38984950",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13543784.2024.2377319"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells.",
"datePublished": "2024-04-25",
"url": "https://questionsmedicales.fr/article/38730608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cancers16091656"
}
},
{
"@type": "ScholarlyArticle",
"name": "The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37551549",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/dom.15216"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia.",
"datePublished": "2023-10-27",
"url": "https://questionsmedicales.fr/article/37897141",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcsm.13346"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis.",
"datePublished": "2023-08-10",
"url": "https://questionsmedicales.fr/article/37635974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1203187"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009419"
},
{
"@type": "ListItem",
"position": 5,
"name": "Neuropeptides",
"item": "https://questionsmedicales.fr/mesh/D009479"
},
{
"@type": "ListItem",
"position": 6,
"name": "Peptide gastrointestinal",
"item": "https://questionsmedicales.fr/mesh/D005749"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Peptide gastrointestinal - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Peptide gastrointestinal",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Peptide gastrointestinal",
"description": "Comment mesurer le GIP dans le sang ?\nQuels tests diagnostiques sont utilisés pour le GIP ?\nLe GIP est-il lié à des maladies spécifiques ?\nQuels symptômes indiquent un déséquilibre du GIP ?\nLe GIP est-il mesuré lors d'examens de routine ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Peptide gastrointestinal",
"description": "Quels symptômes sont liés à un excès de GIP ?\nLe GIP affecte-t-il l'appétit ?\nQuels signes indiquent une carence en GIP ?\nLe GIP est-il impliqué dans des douleurs abdominales ?\nLe GIP influence-t-il la digestion ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Peptide gastrointestinal",
"description": "Comment prévenir les déséquilibres de GIP ?\nLe contrôle du poids influence-t-il le GIP ?\nL'exercice physique affecte-t-il le GIP ?\nLes habitudes alimentaires influencent-elles le GIP ?\nLe stress impacte-t-il le GIP ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Peptide gastrointestinal",
"description": "Comment traiter un excès de GIP ?\nY a-t-il des médicaments ciblant le GIP ?\nLes changements alimentaires aident-ils le GIP ?\nLe GIP peut-il être ciblé par des thérapies hormonales ?\nLes suppléments de GIP sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Peptide gastrointestinal",
"description": "Quelles complications peuvent survenir avec un excès de GIP ?\nLe GIP est-il lié à des maladies cardiovasculaires ?\nDes troubles digestifs peuvent-ils résulter d'un déséquilibre de GIP ?\nLe GIP influence-t-il le risque d'obésité ?\nLe GIP est-il impliqué dans des troubles endocriniens ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Peptide gastrointestinal",
"description": "Quels facteurs augmentent le risque de déséquilibre du GIP ?\nL'alimentation influence-t-elle le GIP ?\nLe manque d'exercice est-il un facteur de risque pour le GIP ?\nLe stress chronique affecte-t-il le GIP ?\nL'âge influence-t-il les niveaux de GIP ?",
"url": "https://questionsmedicales.fr/mesh/D005749#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le GIP dans le sang ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GIP peut être mesuré par un test sanguin spécifique après stimulation alimentaire."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés pour le GIP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de tolérance au glucose et des dosages hormonaux sont utilisés."
}
},
{
"@type": "Question",
"name": "Le GIP est-il lié à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de GIP peuvent être associés au diabète de type 2."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déséquilibre du GIP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hyperglycémie ou des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le GIP est-il mesuré lors d'examens de routine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'est pas couramment mesuré lors des examens de routine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à un excès de GIP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de GIP peut provoquer des nausées, des vomissements et une hyperglycémie."
}
},
{
"@type": "Question",
"name": "Le GIP affecte-t-il l'appétit ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GIP peut influencer la sensation de satiété et l'appétit."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une carence en GIP ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence peut entraîner des problèmes de régulation de la glycémie et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le GIP est-il impliqué dans des douleurs abdominales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de GIP peuvent contribuer à des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Le GIP influence-t-il la digestion ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GIP joue un rôle dans la régulation de la digestion et de l'absorption des nutriments."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres de GIP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et un mode de vie actif peuvent aider à prévenir les déséquilibres."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids influence-t-il le GIP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé peut aider à réguler les niveaux de GIP."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il le GIP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la sensibilité à l'insuline et influencer le GIP."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le GIP ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes alimentaires saines peuvent réguler les niveaux de GIP."
}
},
{
"@type": "Question",
"name": "Le stress impacte-t-il le GIP ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la sécrétion de GIP et la régulation de la glycémie."
}
},
{
"@type": "Question",
"name": "Comment traiter un excès de GIP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des modifications alimentaires et des médicaments antidiabétiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant le GIP ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments antidiabétiques agissent en modulant l'effet du GIP."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils le GIP ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à réguler les niveaux de GIP."
}
},
{
"@type": "Question",
"name": "Le GIP peut-il être ciblé par des thérapies hormonales ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies hormonales peuvent être envisagées pour réguler le GIP dans certains cas."
}
},
{
"@type": "Question",
"name": "Les suppléments de GIP sont-ils disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de suppléments de GIP disponibles sur le marché."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un excès de GIP ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le diabète de type 2 et des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le GIP est-il lié à des maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de GIP peuvent être associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Des troubles digestifs peuvent-ils résulter d'un déséquilibre de GIP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déséquilibre peut entraîner des troubles digestifs comme des ballonnements."
}
},
{
"@type": "Question",
"name": "Le GIP influence-t-il le risque d'obésité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de GIP peuvent contribuer au développement de l'obésité."
}
},
{
"@type": "Question",
"name": "Le GIP est-il impliqué dans des troubles endocriniens ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies du GIP peuvent être liées à des troubles endocriniens comme le syndrome métabolique."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déséquilibre du GIP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le diabète et un mode de vie sédentaire augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le GIP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sucres et en graisses peut perturber le GIP."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque pour le GIP ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie inactif peut contribuer à des déséquilibres du GIP."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il le GIP ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la sécrétion de GIP et la régulation de la glycémie."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de GIP ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de GIP peuvent varier avec l'âge, affectant la régulation métabolique."
}
}
]
}
]
}
Department of Biomedical Sciences and NovoNordisk Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Panum Institute, Copenhagen, Denmark.
Department of Biomedical Sciences and NovoNordisk Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Panum Institute, Copenhagen, Denmark.
State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Science (Ministry of Education), Department of Physics, Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, China.
State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Science (Ministry of Education), Department of Physics, Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, China.
State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Science (Ministry of Education), Department of Physics, Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, China.
State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Science (Ministry of Education), Department of Physics, Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, China.
Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. Electronic address: pingwang@njum.edu.cn.
One billion people live with obesity. The most promising medications for its treatment are incretin-based therapies, based on enteroendocrine peptides released in response to oral nutrients, specifica...
This review describes GLP-1 and GIP physiology and explores the conflicting data regarding GIP and weight management. It details examples of how to reconcile the contradictory findings that both GIP r...
Effects of GIP receptor-modulating compounds on different tissues have implications for both weight reduction and other cardiometabolic diseases. Further study is needed to understand the implications...
Retinoblastoma (RB) is the most common malignant intraocular tumor in early childhood. Gene expression profiling revealed that the gastric inhibitory polypeptide receptor (GIPR) is upregulated followi...
Tirzepatide is a unimolecular co-agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors recently approved for the treatment of type 2 diabetes ...
Intramuscular adipose tissue (IMAT) formation derived from muscle fibro-adipogenic progenitors (FAPs) has been recognized as a pathological feature of sarcopenia. This study aimed to explore whether g...
Whole body composition, grip strength, skeletal muscle weight, tibialis anterior (TA) muscle fibre cross-sectional area (CSA) and TA muscle IMAT area were measured in young and aged male C57BL/6 strai...
Body composition analysis revealed that 104-week-old Gipr...
GIP promotes the differentiation of muscle FAPs into adipocytes and its receptor antagonism suppresses IMAT accumulation and promotes muscle regeneration. Pharmacological GIP receptor antagonism may s...
Glucose-dependent insulinotropic polypeptide (GIP) confers a variety of metabolic benefits in type 2 diabetes mellitus (T2DM). This meta-analysis was conducted to investigate the impact of dipeptidyl ...
Medline (PubMed), CENTER (Cochrane Library), and Embase (Ovid) were searched and randomized controlled trials (RCTs) evaluating the impact of DPP4 inhibitors on fasting and postprandial GIP levels wer...
Overall, 14 RCTs with 541 T2DM patients were included. Compared to placebo/no treatment, the use of DPP4 inhibitors significantly increased the fasting GIP level (standard mean difference [SMD]: 0.77,...
The use of DPP4 inhibitors effectively increases the fasting and postprandial GIP concentrations in T2DM patients....
https://www.crd.york.ac.uk/prospero/, identifier CRD42022356716....
Glucose-dependent insulinotropic polypeptide (GIP) of the incretin group has been shown to exert pleiotropic actions. There is growing evidence that advanced glycation end products (AGEs), senescent m...
Intraduodenal quinine, in the dose of 600 mg, stimulates glucagon-like peptide-1 (GLP-1), cholecystokinin and insulin; slows gastric emptying (GE); and lowers post-meal glucose in men. Oral sensitivit...
Diabetes and obesity are momentous risk factors threatening people's lives and health. Currently available incretin analogue glucagon-like peptide 1 (GLP-1) possesses huge hypoglycemic effect with the...
The agonistic ability of DR10627 was indirectly assessed by inducing cAMP accumulation in Chinese hamster ovary (CHO) cells transfected with GLP-1R or GIPR in vitro. The plasma pharmacokinetics of DR1...
DR10627 had the capacity to activate both GLP-1R and GIPR in vitro. The terminal half-life of DR10627 was found to be approximately 4.19-5.8 h in cynomolgus monkeys. DR10627 had a great improvement in...
Preclinical assessment demonstrated that administration of DR10627 resulted in glucose lowering in SD rats and...
Bariatric surgery is the most effective treatment in individuals with obesity to achieve remission of type 2 diabetes. Post-bariatric surgery hypoglycaemia occurs frequently, and management remains su...
The study protocol was prospectively registered with PROSPERO. PubMed, EMBASE, Web of Science and the Cochrane databases were searched for publications between January 1990 and November 2021 using MeS...
From 377 identified publications, 12 were included in the analysis. In all 12 studies, the type of bariatric surgery was Roux-en-Y gastric bypass (RYGB). Comparing individuals with and without post-ba...
Following RYGB, postprandial peak plasma GLP-1, insulin and C-peptide concentrations are greater in individuals with post-bariatric surgery hypoglycaemia, while HbA...
Spasmolytic polypeptide-expressing metaplasia (SPEM) is a trefoil factor 2-expressing metaplasia in the fundic glands that resembles the fundic metaplasia of deep antral glandular cells and arises mai...